EpiBone

Epi Bone

Biotechnology, 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States, 11-50 Employees

epibone.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 21********

Who is EPIBONE

EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the ...

Read More

map
  • 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States Headquarters: 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Nina Tandon CEO:   Nina Tandon

industries-icon Industry: Biotechnology

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from EPIBONE

EpiBone Org Chart and Mapping

Nina Tandon

Chief Executive Officer

Employees

Kellen Kennedy

Engineering Research Technician

Cornell Wu

Cartilage Tissue Specialist

Robert Stefani

Consultant (Research Scientist)

Poonam Sharma

Senior Manager Quality Control (Tissue Engineering/ Cell Therapy)

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding EpiBone

Answer: EpiBone's headquarters are located at 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States

Answer: EpiBone's phone number is 21********

Answer: EpiBone's official website is https://epibone.com

Answer: EpiBone's revenue is $1 Million to $5 Million

Answer: EpiBone's SIC: 3841

Answer: EpiBone's NAICS: 339112

Answer: EpiBone has 11-50 employees

Answer: EpiBone is in Biotechnology

Answer: EpiBone contact info: Phone number: 21******** Website: https://epibone.com

Answer: EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access